Mad Money W/ Jim Cramer

CNBC's Mad Money with Jim Cramer.

The Dow closed up 33 points with all three major indices hitting record highs, and Cramer’s breaking down today’s biggest headlines. Then, over the past four years Dexcom’s stock has more than quadrupled, so could the strong trend continue? Cramer’s sitting down with the company’s CEO. Then, last year at the JPMorgan Healthcare Conference, Cramer spoke with Medtronic’s CEO about some short-term headwinds that Wall Street didn’t like. Since then, the stock has skyrocketed and tonight Cramer’s getting an update from the CEO. And, has the market gotten too complacent? Cramer’s going ‘Off the Charts’ on the VIX to make sense of the fear gauge as the market continues to hit record highs.  

CNBC's Mad Money with Jim Cramer.

CNBC's Mad Money with Jim Cramer.

CNBC's Mad Money with Jim Cramer.

The Dow closed up 161 points today and Jim Cramer’s breaking down today’s biggest movers. Then Constellation Brands soared over 3.5% today, so what should you make of the everchanging beverage space and its stake in Canopy Growth? Cramer’s sitting down with the CEO. Then, Cramer has previously revealed his ‘Humanization of Pets Index’, and tonight he’s revealing two clear winner that might be worth looking at. Plus, Cramer’s turning in his homework on Sea Limited to understand the stock’s monster run. 

CNBC's Mad Money with Jim Cramer.

The Dow closed up 69 points to kick off the first full trading week of 2020 and Jim Cramer’s breaking down today’s headlines. Then, the new year brings new resolutions, and one of those is usually a focus on fitness. Tonight, Cramer’s sitting down with Planet Fitness’ CEO to learn more about its push for 2020 and to hear more about his story from front desk to CEO. And, Axon Enterprise finds itself caught in the crosshairs with a focus from the FTC. After filing a lawsuit against the FTC, should investors continue to hold the stock through the headlines? Cramer’s sitting down with the company’s CEO. Plus, Cramer’s looking at the defense sector and giving you his playbook.

The Dow closed down 234 points and Jim Cramer’s making sure you’re ready to take on the first full week of 2020 with his game plan. Then, it’s been a rocky road since CrowdStrike came public in 2019, but after today’s pop in the stock, is it back in favor on Wall Street? Cramer’s getting to the core of the company with its CEO. Plus, there were some clear winners in the Dow and S&P for 2019, and tonight Cramer’s digging into the top 10 from each index to see if these winners can keep on winning in 2020. 

Jim Cramer has spent a career on Wall Street getting to know the inner workings of how our financial system works, and tonight he’s pulling back the curtain and revealing the Wall Street lingo that you need to know to be a successful investor. From secular and cyclical plays, to the metrics you need to know to do efficient homework, this show is all about making you a smarter investor and demystifying the market. 

CNBC's Mad Money with Jim Cramer.

Every now and then there may be a blip in the tape and the wave of green turns into a sea of red. Jim Cramer has been at this game for a long time and has experienced his share of sell-offs, and tonight, he’s giving you his strategies for managing any sell-off the market may throw at you.

Jim Cramer’s been at this game for a long time, and tonight he’s taking his accumulated wisdom and laying it out in his rules for managing your own money. From stock picking to understanding dividends, this show is all about taking a peak behind the curtain so you can grow your wealth just like the pros. 

Jim Cramer knows that sometimes it’s important to pull away from the madness of Wall Street and just understand the basics. Tonight, Cramer’s giving you his economics playbook to make sure you understand the market on a whole new level. This is a modern day economics lesson that you can‘t afford to miss! 

The American education system has taught you chemistry, geometry, and physics, but what about financial literacy? Tonight, Jim Cramer’s giving you his playbook for managing a financially-stable life. From contributing to a 401k to understanding the many different funds that the market offers, this show is all about demystifying a world that is often not taught in school. It may be winter break, but class is in session and Professor Cramer is ready to help you navigate any financial confusion you may have.  

The Dow closed up 78 points today and Jim Cramer’s revealing 12 things that he wants from the market going into the new year. And, don’t be a pig- Arrowhead Pharma and InMode have rallied recently, and Cramer’s teaching a lesson about when to take profits. Then, the CEO of Paychex, Marty Mucci, is here to talk about the company’s recent earnings and where the stock is headed into the new year. Also, take out your notebook, because Cramer’s turning in his homework on Allakos and Global Blood Therapeutics.

The Dow skyrocketed 138 points today and Jim Cramer’s breaking down today’s rally, with the Dow, S&P, and Nasdaq breaking all-time highs. Then, it was the year of the IPO, but which one’s deserve Cramer’s praise now that we’re heading into 2020? And, CEO of Emergent BioSolutions Robert Kramer sits down with Cramer to talk about the company’s growth, new acquisitions, and a 40% rally from its lows in August. Plus, Sudheesh Nair, CEO of ThoughtSpot, discusses where what the private start-up’s mission could mean for the data analytics industry.

The Dow closed down today 28 points and Jim Cramer’s looking at today’s action and updating you on what the impeachment vote means for your money. Then, Cramer’s breaking down how the markets moved in 1998 and 1999 when former President Bill Clinton was impeached and how curtained stocks fared while everyone watched what was going on in Washington. And, huddle up- Cramer’s digging into FedEx’s disappointing earnings call today and what’s in store for the stock going forward.

The Dow closed up 31 points hitting another all-time high and Cramer’s digging into today’s biggest movers. Then, the drug companies have been caught in political crosshairs, and Cramer’s getting to the core of it with Eli Lilly’s CEO. And, with the market at all-time highs, are there any bargains out there? Cramer’s going off the charts to look at bargain buys during market highs. And you’ve called in and stumped Professor Cramer, and tonight he’s turning in his homework on Wave Life Sciences and sharing what lessons he has learned through his research into speculative biotech names. 

The Dow closed up 101 points with all three major indices hitting record highs and Jim Cramer’s breaking down today’s headlines. Then, S&P Global has had a powerful year, so what should you make of the company behind the benchmark index? Cramer’s sitting down with the company’s CEO to discuss its latest acquisitions and newest products. And, last week Bill.com hit the tape and immediately surged 69% higher, and Cramer’s digging into this new IPO and seeing if this was the listing that the 2019 IPO market needed to end the year on a high note. Plus, Cramer’s sitting down with Livongo Health’s founder and executive chairman to make sense of this recent IPO and the volatility the stock has experienced since hitting the public market.